Patent · US Active

Liposomal formulation for the oral hepatic delivery of drugs

US10716757B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Universität Heidelberg · DE

Inventors

Gert Fricker · Dossenheim, DE
Walter Mier · Bensheim, DE
Frieder Helm · Heidelberg, DE
Philipp Uhl · Heidelberg, DE
Stephan Urban · Neustadt, DE

Key dates

Filing date	Oct 11, 2016
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Oct 11, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2123/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to liposomal compositions, comprising liposomes containing tetraether lipids (TELs), and further comprising the lipopeptide Myr-HBVpreS/2-48 (Myrcludex B) as part of said liposomes, as well as uses thereof for the prevention or treatment of hepatic disorders or diseases, and/or for the oral hepatic delivery of therapeutic and/or diagnostic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.